London-based clinical research organisation Quanticate has appointed Alan Morgan as its chief operating officer.
Morgan will oversee the data-focused firm’s global office network across India, Poland, South Africa, the UK and the US with a view to expanding its client base in clinical data services.
He joins from both Oxfordshire Life Sciences, a consulting and advisory service, where he served as managing director, and pharma services provider Concept Life sciences, which he co-founded in 2014 and served as its chief executive.
Previously, Morgan served as ICON’s group president for clinical research services, and has held a number of finance management roles at AstraZeneca, Covance, GlaxoSmithKline, MDS and RPS.
David Underwood, chief executive of Quanticate, said: “Alan will be a real asset to both Quanticate and our customers as he will help to continue to optimize our processes while providing strategic direction for the future.
“As the clinical data experts, Alan’s leadership over our operational teams will ensure the highest quality is delivered at all times to our customers and our leading position in the marketplace as a niche data-focused CRO is continually strengthened.”